Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
doi: https://doi.org/10.1038/d41586-020-01295-8
Updates & Corrections
-
Update 04 May 2020: This story has been updated to note that on 1 May US regulatory authorities granted remdesivir ‘emergency use’ authorization for use in people with severe COVID-19.
References
Wang, Y. et al. Lancet https://doi.org/10.1016/S0140-6736(20)31022-9 (2020).
Wang, M. et al. Cell Res. 30, 269–271 (2020).
Cao, B. et al. N. Engl. J. Med. https://doi.org/10.1056/NEJMoa2001282 (2020).
Sheahan, T. P. et al. Sci. Transl. Med. 12, eabb5883 (2020).